Synopsis
0
KDMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
29
PharmaCompass offers a list of Cloxacillin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cloxacillin Sodium manufacturer or Cloxacillin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cloxacillin Sodium manufacturer or Cloxacillin Sodium supplier.
A Cloxapen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloxapen, including repackagers and relabelers. The FDA regulates Cloxapen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloxapen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cloxapen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Cloxapen supplier is an individual or a company that provides Cloxapen active pharmaceutical ingredient (API) or Cloxapen finished formulations upon request. The Cloxapen suppliers may include Cloxapen API manufacturers, exporters, distributors and traders.
click here to find a list of Cloxapen suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Cloxapen DMF (Drug Master File) is a document detailing the whole manufacturing process of Cloxapen active pharmaceutical ingredient (API) in detail. Different forms of Cloxapen DMFs exist exist since differing nations have different regulations, such as Cloxapen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cloxapen DMF submitted to regulatory agencies in the US is known as a USDMF. Cloxapen USDMF includes data on Cloxapen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cloxapen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cloxapen suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cloxapen Drug Master File in Japan (Cloxapen JDMF) empowers Cloxapen API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cloxapen JDMF during the approval evaluation for pharmaceutical products. At the time of Cloxapen JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cloxapen suppliers with JDMF on PharmaCompass.
A Cloxapen CEP of the European Pharmacopoeia monograph is often referred to as a Cloxapen Certificate of Suitability (COS). The purpose of a Cloxapen CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cloxapen EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cloxapen to their clients by showing that a Cloxapen CEP has been issued for it. The manufacturer submits a Cloxapen CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cloxapen CEP holder for the record. Additionally, the data presented in the Cloxapen CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cloxapen DMF.
A Cloxapen CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cloxapen CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cloxapen suppliers with CEP (COS) on PharmaCompass.
A Cloxapen written confirmation (Cloxapen WC) is an official document issued by a regulatory agency to a Cloxapen manufacturer, verifying that the manufacturing facility of a Cloxapen active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cloxapen APIs or Cloxapen finished pharmaceutical products to another nation, regulatory agencies frequently require a Cloxapen WC (written confirmation) as part of the regulatory process.
click here to find a list of Cloxapen suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cloxapen as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cloxapen API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cloxapen as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cloxapen and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cloxapen NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cloxapen suppliers with NDC on PharmaCompass.
Cloxapen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cloxapen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cloxapen GMP manufacturer or Cloxapen GMP API supplier for your needs.
A Cloxapen CoA (Certificate of Analysis) is a formal document that attests to Cloxapen's compliance with Cloxapen specifications and serves as a tool for batch-level quality control.
Cloxapen CoA mostly includes findings from lab analyses of a specific batch. For each Cloxapen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cloxapen may be tested according to a variety of international standards, such as European Pharmacopoeia (Cloxapen EP), Cloxapen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cloxapen USP).
